Skip to main content
. 2017 Jan 31;12(1):e0170431. doi: 10.1371/journal.pone.0170431

Fig 3. Survival analysis of miR-33a expression and chemotherapy in NSCLCs.

Fig 3

Univariate survival analysis of overall survival and disease-free survival in lung carcinoma as determined by Kaplan-Meier plots estimates based on chemotherapy (Negative vs. Positive) in (A) and (B), miR-33a expression (Low vs. High) in (C) and (D), and miR-33a expression and chemotherapy (non-chemotherapy and low miR-33a expression vs. chemotherapy and high miR-33a expression) in (E) and (F), respectively.